Swiss Private Equity & Corporate Finance Association
Schweizerische Vereinigung für Unternehmensfinanzierung
Association Suisse des Investisseurs en Capital et de Financement
E | D | F

Status

Full Member

Contact

StreetRue de la Confédération 7 
(View on map)
Zip / Town1204 Geneva
CountrySwitzerland

1st ContactMr. Bernard Vogel
2nd ContactMs. Silke Wood

Telephone+41 22 544 60 00

E-Mailsw [SECURE E-MAIL - REWRITE MANUALLY] *at* endeavourvision.com
1st E-Mailbv [SECURE E-MAIL - REWRITE MANUALLY] *at* endeavourvision.com
2nd E-Mailsw [SECURE E-MAIL - REWRITE MANUALLY] *at* endeavourvision.com
WebsiteVisit

Login



Forgotten password

Visit us on LinkedIn!

Endeavour Vision

Endeavour Vision is a private equity firm, focused exclusively on supporting growth-stage healthcare technology companies. The company’s mission is to transform the standard of care for millions of patients by investing in groundbreaking medical innovations. Endeavour Vision’s team offers unmatched sector and operational expertise, extensive international experience including product launches and accelerating company growth, in addition to a proven track record of successful exits. The firm's recent investments include Sophia Genetics (IPO 2021), Medartis (IPO in 2018), Vertiflex (acquired by Boston Scientific in 2019) and Symetis (acquired by Boston Scientific in 2017). The company headquarters are in Geneva, Switzerland with further presence in North America.



Investments

Type of firmAll
Investment StagesExpansion - Development Capital
Industrial SectorsMedical - Life Sciences - Health Related
Geographical FocusEurope, United States of America
Type of financingEquity Financing

Company Profile

Number of Employees in Switzerland11
Capital under Management870m
Fund NamesEndeavour II LP, Endeavour Medtech Growth LP, Endeavour Medtech Growth II LP
Number of Portfolio Companies22
Examples of Portfolio CompaniesSophia Genetics, Medartis, Intelycare, CeQur, Willow
Year of Establishment2000
Size of Investment20-40m
Available Funds175m
Minimum investment considered10m
Maximum investment considered40m
Average equity stake5-25%
Timescale for investments3-5 years
Source of fundsinstitutional and private investors
Preferred exit routeTrade sale or IPO

Full Members
Contact

Swiss Private Equity & Corporate Finance Association
SECA
Grafenauweg 10
Postfach 4332
6304 Zug
Switzerland

Phone: +41 41 724 65 75